Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Gastric Cancer × relatlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Advanced Cancer 2 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Hodgkin Disease 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Chordoma 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advanced Gastric Cancer 1

Interventions

Oxaliplatin 5 Capecitabine 5 Cisplatin 4 Paclitaxel 3 Fluorouracil 3 camrelizumab 2 apatinib 2 S 1 (combination) 2 Leucovorin 2 Docetaxel 2 titanium silicide 1 rucaparib 1 relatlimab 1 pazopanib 1 linrodostat 1 ezogabine 1 endostar protein 1 dacomitinib 1 capivasertib 1 Sunitinib 1 Nivolumab 1 Metabolic Networks and Pathways 1 Irinotecan 1 Ipilimumab 1 Everolimus 1 Epirubicin 1 Electroporation 1 Drug Therapy, Combination 1 Drug Therapy 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡